Skip to main content
Clinical Trials/ISRCTN42633050
ISRCTN42633050
Completed
Not Applicable

Clinical and histologic effect of transrectal intraprostatic injections with botulinum toxin A in patients with lower urinary tract symptoms caused by benign prostatic hyperplasia

niversity Medical Center Utrecht (UMCU) (The Netherlands)0 sites20 target enrollmentNovember 22, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Benign prostatic hyperplasia
Sponsor
niversity Medical Center Utrecht (UMCU) (The Netherlands)
Enrollment
20
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 22, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
niversity Medical Center Utrecht (UMCU) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age more than 55
  • 2\. Signed informed consent
  • 3\. Lower Urinary Tract Symptoms (LUTS) with International Prostatic Symptom Score (IPSS) more than seven
  • 4\. Insufficient response to oral medication
  • 5\. Prostatic volume 30 to 50 ml
  • 6\. Urodynamic infravesical obstruction more than grade II according to Schafer
  • 7\. Willing and able to fill out questionnaires and voiding diaries
  • 8\. Willing and able to attend proposed investigations

Exclusion Criteria

  • 1\. Neuropathic bladder dysfunction
  • 2\. Prostatic carcinoma
  • 3\. Coagulation disorder
  • 4\. Urinary tract infection
  • 5\. Bladder calculus
  • 6\. Post\-renal renal insufficiency
  • 7\. Myopathic disorder
  • 8\. Anatomical defects preventing transrectal approach

Outcomes

Primary Outcomes

Not specified

Similar Trials